T-cell therapy for viral infections after hematopoietic stem cell transplantation in the 55th ASH annual meeting / 白血病·淋巴瘤
Journal of Leukemia & Lymphoma
; (12): 7-8, 2014.
Artigo
em Chinês
| WPRIM (Pacífico Ocidental)
| ID: wpr-475323
Biblioteca responsável:
WPRO
ABSTRACT
Viral infections remain a major cause of morbidity in patients with immunodeficiency,such as recipients of hematopoietic stem cell transplantation (HSCT).Adoptive transfer of donor-derived virusspecific cytotoxic T lymphocytes is a strategy to restore virus-specific immunity to prevent or treat viral diseases and has been tested in the clinical setting for more than 20 years.The 55th ASH annual meeting reported lots of basic and clinical experience about CTL and summarized lots of trails to evaluate it,which will give us some new thought about the antivirus therapy after HSCT.
Texto completo:
Disponível
Base de dados:
WPRIM (Pacífico Ocidental)
Idioma:
Chinês
Revista:
Journal of Leukemia & Lymphoma
Ano de publicação:
2014
Tipo de documento:
Artigo